Simpson Thacher Represents Shanghai Weicon Optical and its Founder in Strategic Investment
06.25.14
This is only gets display when printing
Simpson Thacher is representing Shanghai Weicon Optical Co., Ltd. ("Shanghai Weicon") and its founder in connection with the strategic investment by China Grand Pharmaceutical and Health Holdings Limited and CDH Fund V, L.P. in Shanghai Weicon. Shanghai Weicon is a leading contact lenses and solutions manufacturer in China. The transaction values Shanghai Weicon at approximately US$100 million. The closing of the transaction is subject to customary regulatory approvals.
The Simpson Thacher team working on this transaction includes: Chris Lin (Hong Kong), Yang Wang and Duan Fu (Beijing).